Skip to contentS
Skye Bioscience, Inc.
S
SKYESkye Bioscience, Inc. Released Aug 13, 2020, after the close
10-Q filed Aug 13, 2020, 44 days after period end · 0001640334-20-002095
Q2 2020 · 10-Q
Revenue—
Net Income-$1.42M-$1.42MN/M vs Q2 2019N/M vs Q1 2020 No earnings release is on file for this quarter. Its figures came with the 10-Q.
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Skye Bioscience, Inc. · CIK 1516551 · Engraved from SEC EDGAR
EPS Diluted
-$0.01-$0.01N/M vs Q2 2019N/M vs Q1 2020 Operating Income-$1,220,658N/M Operating Cash Flowderived-$1,028,040N/M Free Cash Flowderived-$1,028,040— Filing lag
ended Jun 30, 2020 · filed Aug 13, 2020 · 44 d after period end